Stocks and Investing Stocks and Investing
Fri, March 3, 2023
Thu, March 2, 2023

Benjamin Chaiken Maintained (ALLO) at Hold with Decreased Target to $19 on, Mar 2nd, 2023


Published on 2024-10-28 02:04:37 - WOPRAI, Benjamin Chaiken
  Print publication without navigation


Benjamin Chaiken of JMP Securities, Maintained "Allogene Therapeutics, Inc." (ALLO) at Hold with Decreased Target from $23 to $19 on, Mar 2nd, 2023.

Benjamin has made no other calls on ALLO in the last 4 months.



There are 7 other peers that have a rating on ALLO. Out of the 7 peers that are also analyzing ALLO, 0 agree with Benjamin's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Benjamin


  • Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $22 on, Wednesday, March 1st, 2023
  • Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $28 on, Wednesday, March 1st, 2023
  • Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $15 on, Wednesday, March 1st, 2023
  • Brian Cheng of "JP Morgan" Upgraded from Hold to Buy and Decreased Target to $11 on, Tuesday, January 24th, 2023
  • Jack Allen of "Baird" Upgraded from Hold to Buy and Held Target at $12 on, Friday, January 6th, 2023
  • Jason Gerberry of "B of A Securities" Downgraded from Strong Buy to Sell and Held Target at $9 on, Monday, December 12th, 2022
  • Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $29 on, Monday, November 21st, 2022
Contributing Sources